Annual SG&A
$62.77 M
-$68.09 M-52.03%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual selling, general & administrative expenses is currently $62.77 million, with the most recent change of -$68.09 million (-52.03%) on 31 December 2023. During the last 3 years, it has risen by +$46.72 million (+291.19%). BHVN annual SG&A is now -53.31% below its all-time high of $134.45 million, reached on 31 December 2019.BHVN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$20.56 M
+$1.61 M+8.48%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly selling, general & administrative expenses is currently $20.56 million, with the most recent change of +$1.61 million (+8.48%) on 30 September 2024. Over the past year, it has increased by +$5.53 million (+36.80%). BHVN quarterly SG&A is now -83.53% below its all-time high of $124.80 million, reached on 01 June 2020.BHVN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.34 B
-$804.34 M-31.78%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM selling, general & administrative expenses is currently -$3.34 billion, with the most recent change of -$804.34 million (-31.78%) on 30 September 2024. Over the past year, it has dropped by -$3.46 billion (-2874.06%). BHVN TTM SG&A is now -4320.49% below its all-time high of $462.32 million, reached on 01 December 2020.BHVN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.0% | +36.8% | -2874.1% |
| 3 y3 years | +291.2% | +126.8% | -10000.0% |
| 5 y5 years | +81.4% | -70.2% | -2580.9% |
BHVN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -52.0% | +291.2% | -73.1% | +141.3% | -3560.4% | at low |
| 5 y | 5 years | -53.3% | +291.2% | -83.5% | +141.3% | -3560.4% | +49.4% |
| alltime | all time | -53.3% | +2837.3% | -83.5% | +3254.2% | -4320.5% | +49.4% |
Biohaven Pharmaceutical Holding Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $20.56 M(+8.5%) | $85.68 M(+6.9%) |
| June 2024 | - | $18.95 M(-30.5%) | $80.15 M(+5.9%) |
| Mar 2024 | - | $27.27 M(+44.3%) | $75.72 M(+20.6%) |
| Dec 2023 | $62.77 M(-52.0%) | $18.90 M(+25.7%) | $62.77 M(-47.8%) |
| Sept 2023 | - | $15.03 M(+3.5%) | $120.24 M(+0.2%) |
| June 2023 | - | $14.52 M(+1.4%) | $120.00 M(-4.4%) |
| Mar 2023 | - | $14.32 M(-81.2%) | $125.50 M(-4.1%) |
| Dec 2022 | $130.86 M(+249.8%) | $76.37 M(+416.3%) | $130.86 M(+105.9%) |
| Sept 2022 | - | $14.79 M(-26.1%) | $63.56 M(+11.0%) |
| June 2022 | - | $20.02 M(+1.8%) | $57.28 M(+53.7%) |
| Mar 2022 | - | $19.68 M(+117.1%) | $37.26 M(+111.9%) |
| Dec 2021 | $37.41 M(+133.2%) | - | - |
| Dec 2021 | - | $9.06 M(+6.4%) | $17.58 M(-86.6%) |
| Sept 2021 | - | $8.52 M(-93.0%) | $130.91 M(-71.7%) |
| Dec 2020 | $16.05 M(-88.1%) | - | - |
| Dec 2020 | - | $122.39 M(+2.4%) | $462.32 M(+13.1%) |
| Sept 2020 | - | $119.53 M(-4.2%) | $408.92 M(+28.5%) |
| June 2020 | - | $124.80 M(+30.5%) | $318.16 M(+46.9%) |
| Mar 2020 | - | $95.60 M(+38.6%) | $216.59 M(+61.1%) |
| Dec 2019 | $134.45 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | $68.98 M(+139.7%) | $134.45 M(+77.9%) |
| Sept 2019 | - | $28.78 M(+23.9%) | $75.58 M(+39.0%) |
| June 2019 | - | $23.23 M(+72.6%) | $54.37 M(+35.2%) |
| Mar 2019 | - | $13.46 M(+33.1%) | $40.20 M(+16.2%) |
| Dec 2018 | $34.60 M(+90.7%) | - | - |
| Dec 2018 | - | $10.11 M(+33.5%) | $34.60 M(+14.9%) |
| Sept 2018 | - | $7.57 M(-16.4%) | $30.11 M(+11.1%) |
| June 2018 | - | $9.06 M(+15.4%) | $27.11 M(+21.9%) |
| Mar 2018 | - | $7.86 M(+40.0%) | $22.24 M(+22.6%) |
| Dec 2017 | $18.14 M(+255.1%) | - | - |
| Dec 2017 | - | $5.61 M(+22.8%) | $18.14 M(+21.1%) |
| Sept 2017 | - | $4.57 M(+8.9%) | $14.98 M(+32.2%) |
| June 2017 | - | $4.20 M(+11.8%) | $11.33 M(+37.3%) |
| Mar 2017 | - | $3.76 M(+53.2%) | $8.25 M(+61.5%) |
| Dec 2016 | $5.11 M(+139.1%) | - | - |
| Dec 2016 | - | $2.45 M(+166.5%) | $5.11 M(+92.3%) |
| Sept 2016 | - | $920.00 K(-18.1%) | $2.66 M(+53.0%) |
| June 2016 | - | $1.12 M(+83.4%) | $1.74 M(+183.4%) |
| Mar 2016 | - | $613.00 K | $613.00 K |
| Dec 2015 | $2.14 M | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual SG&A year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly SG&A year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM SG&A year-on-year change?
What is Biohaven Pharmaceutical Holding annual selling, general & administrative expenses?
The current annual SG&A of BHVN is $62.77 M
What is the all time high annual SG&A for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual selling, general & administrative expenses is $134.45 M
What is Biohaven Pharmaceutical Holding annual SG&A year-on-year change?
Over the past year, BHVN annual selling, general & administrative expenses has changed by -$68.09 M (-52.03%)
What is Biohaven Pharmaceutical Holding quarterly selling, general & administrative expenses?
The current quarterly SG&A of BHVN is $20.56 M
What is the all time high quarterly SG&A for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly selling, general & administrative expenses is $124.80 M
What is Biohaven Pharmaceutical Holding quarterly SG&A year-on-year change?
Over the past year, BHVN quarterly selling, general & administrative expenses has changed by +$5.53 M (+36.80%)
What is Biohaven Pharmaceutical Holding TTM selling, general & administrative expenses?
The current TTM SG&A of BHVN is -$3.34 B
What is the all time high TTM SG&A for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM selling, general & administrative expenses is $462.32 M
What is Biohaven Pharmaceutical Holding TTM SG&A year-on-year change?
Over the past year, BHVN TTM selling, general & administrative expenses has changed by -$3.46 B (-2874.06%)